Morning all,
It's getting a little difficult to remember all of the updates that are pending from already announced programs/agreements/partnerships.
Due soonish (by the end of June) are previously Incannex published milestones...
IHL-42X - Opening of IND with USA FDA
IHL-42X- Start of Phase2/3 Trial in USA
IHL-675A - Pre-Ind Meeting with USA FDA
Plus....Followups from any of the following..
For all new Shareholders, I have added some links to make it easy for you to check back on the relevant ASX announcement.
>> Update on the PSI-GAD Patent Filing & IP Strategy/Methodology moving forward for PSI treatment/s?
>> Update on GMP Manufacture of Psilocybin for PSI-GAD by Catalent
https://stocknessmonster.com/announcements/ihl.asx-3A614236/
>> Reverse "over liquid" ASX to resolve the "lack of liquidity" on the Nasdaq.
Quote from Joel "volumes on Nasdaq are currently less than on the ASX, we potentially foresee a time whereby this situation is reversed"
https://stocknessmonster.com/announcements/ihl.asx-3A608385/
>> Ethics Committee (HREC) Approval - BA/BE Study IHL-42X (Sleep Apnoea) at C-MAX S.A.
>> Commencement of BA/BE IHL-42X Study...
https://stocknessmonster.com/announcements/ihl.asx-3A607321/
>> Ethics Committee (HREC) Approval - Phase 2 Trial IHL-675A (Rheumatoid Arthritis)
>> Trial Locations / Institutions - Phase 2 IHL-675A (Rheumatoid Arthritis)
"8-10 clinical trial sites across Australia and New Zealand, recruiting 120 patients in total"
https://stocknessmonster.com/announcements/ihl.asx-3A613867/
>> Manufacturing Update from Eurofins re manufacture and test chewable products to alleviate nicotine and opioid addiction.
https://stocknessmonster.com/announcements/ihl.asx-3A608255/
>> CRO Update - Quest Pharmaceutical Services (‘QPS’) to provide regulatory advice and manage clinical trials for the
development of CannQuit™ and ReneCann™ products for addiction and immune-disordered skin diseases.
https://stocknessmonster.com/announcements/ihl.asx-3A616480/
>> Psychedelics - VR agreement/licensing arrangement/extension & and/or other anxiety indications with Monash?
https://stocknessmonster.com/announcements/ihl.asx-3A589013/
>> Manufacturing update from Curia on the inhaled device for IHL-216A
https://stocknessmonster.com/announcements/ihl.asx-3A598294/
>> Clarion Clinics - Update on Abbotsford "Model Clinic" ... location..fitout..premises to be ready before September.....update on supply of psilocybin & MDMA from Pharmala? TGA Requirements.. HREC approval?
https://stocknessmonster.com/announcements/ihl.asx-3A617811/
>> Bob Clarke update later in the year maybe??
Section 10 AGM
https://stocknessmonster.com/announcements/ihl.asx-3A605146/
Good luck to all holders
- Forums
- ASX - By Stock
- General discussion
Morning all,It's getting a little difficult to remember all of...
-
- There are more pages in this discussion • 3,984 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online